Financials

News Discussions Technicals Forecast Seasonals

AVBP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of ArriVent BioPharma, Inc.

Total assets of AVBP for Q3 24 is 292.71 M USD, 5.23% less than the previous Q2 24. And total liabilities increased by 24.78% in Q3 24 to 15.22 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—